Subcutaneous amycretin phase 1b/2a data on the safety, tolerability and weight loss potential in people with overweight or obesity was…
June 20, 2025 19:30 ET | Source: Structure Therapeutics Inc. SAN FRANCISCO, June 20, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics…
BROOKLYN, June 19, 2025 (GLOBE NEWSWIRE) -- HealthRX, a digital health platform serving adults across the United States, has announced…
MELBOURNE, Australia and INDIANAPOLIS, June 20, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”, “the Company”)…
MONTRÉAL, June 19, 2025 (GLOBE NEWSWIRE) -- Premier Health of America Inc. (TSXV: PHA) (the “Company” or “Premier Health”), a…
IRVINE, Calif., June 19, 2025 (GLOBE NEWSWIRE) -- MorningStar Laboratories, LLC., (“MSL” or “the Company”), a leading developer of precision diagnostic…
June 19, 2025 16:05 ET | Source: The Ensign Group, Inc. SAN JUAN CAPISTRANO, Calif., June 19, 2025 (GLOBE NEWSWIRE)…
Certified Method Enhances Global Botanical Quality and Safety BENGALURU, India, June 19, 2025 /PRNewswire/ -- Herbalife Ltd. (NYSE: HLF), a premier health and wellness company, community…
June 19, 2025 01:00 ET | Source: Addex Therapeutics Strong cash position of CHF2.8 million at end of Q1 2025GABAB…
June 18, 2025 17:36 ET | Source: Psyence Group Inc. TORONTO, June 18, 2025 (GLOBE NEWSWIRE) -- Psyence Group Inc.…